Heska Corporation trades as part of the healthcare sector and is in the medical diagnostics and research industry. The company CEO is Kevin S. Wilson. Heska Corp is engaged in developing, manufacturing, marketing, selling and supporting veterinary products. The Company’s core focus is on the canine and feline companion animal health markets.
Previous Intraday Performance:
The HSKA shares had a previous change of -1.60% which opened at 76.10 and closed at 74.66. It moved to an intraday high of 76.46 and a low of 74.00.
Over the last five trading days, HSKA shares returned -5.95% and in the past 30 trading days it returned -3.42%. Over three months, it changed -17.41%. In one year it has changed -5.40% and within that year its 52-week high was 114.50 and its 52-week low was 71.60. HSKA stock is 4.27% above its 52 Week Low.
Our calculations result in a 200 day moving average of 96.96 and a 50 day moving average of 85.76. Right now, HSKA stock is trading -23.00% below its 200 day moving average and may not be a great opportunity to buy as it may continue to trend down.
The company has a market cap of $578.0m with 7.7m shares outstanding and a float of 6.7m shares. Trading volume was 64,892 shares and has experienced an average volume of 70,697 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.
The last annual reported EPS for Heska Corporation was 0.73 which ended on 31st of December 2018, which according to the previous close, that is a PE of 102.27. The trailing twelve month EPS is 1.44, which comes to a trailing twelve month PE of 51.85.
Base on our calculations, the intrinsic value per share is 13.69, which means it might overvalued by -445.25%
The next earnings report will be: 05-07-2019
EPS growth is an important number as it indicates the future prospects of Heska Corporation; it is usually expressed as a percentage and is then referred to as the EPS growth rate, which at this time is hard to estimate, but revenue growth has been -4.10% over the last twelve months.
Indicators Also to Watch:
Based on the latest filings, there is 144.60% of institutional ownership.
I calculated the beta to be 0.75
SeekingAlpha: Landmark Bancorp reports Q4 results
Based on last reported financials, the company’s return on equity is 5.35%, return on assets is 4.09%, profit margin is 3.96%, price-to-sales is 6.20 and price-to-book is 4.80.
Company Score Card:
Results are out of six:
4 : Growth Expectations Result
6 : Financial Safety Result
1 : Past Performance Result
0 : Valuation Result
0 : Dividend Safety Result
2 : Overall Result